Graft Failure After Pediatric Penetrating Keratoplasty in the United States

美国儿童穿透性角膜移植术后移植失败

阅读:1

Abstract

PURPOSE: In contrast to adult patients, corneal transplants performed in pediatric patients tend to fare poorly, with relatively higher graft failure rates. The purpose of this study was to analyze the indications and outcomes of pediatric patients undergoing penetrating keratoplasty (PK). METHODS: This retrospective cohort study included children ≤18 years in the IRIS Registry (Intelligent Research in Sight) who underwent PK (January 1, 2013-December 31, 2020). Corneal graft failure was identified using International Classification of Diseases codes. The Kaplan-Meier estimated 5-year cumulative incidence of graft failure after PK. Hazard ratios (HR) derived from multivariable Cox regression models were used to evaluate the association of graft failure with sociodemographic and clinical factors. RESULTS: Five hundred forty-four children underwent PK (median age 15 years; 43% [234] female). Indications for surgery included nontraumatic acquired (58%, N = 318), congenital (18%, N = 100), other (9.6%, N = 52), and traumatic acquired (8.6%, N = 47). The cumulative incidence of graft failure within 5 years of PK was 50% (95% confidence intervals [CI], 45%-56%). The incidences did not differ between patients in various etiology groups. Graft failure was associated with glaucoma (HR, 1.46; 95% CI, 1.05-2.01; P = 0.023), dry eye disease (HR, 1.86; 95% CI, 1.18-2.92; P = 0.007), and corneal neovascularization (HR, 1.76; 95% CI, 1.00-3.08; P = 0.050). CONCLUSIONS: Approximately half of children undergoing PK in the IRIS Registry experienced graft failure within 5 years of transplantation. The association of graft failure with ocular conditions such as glaucoma and dry eye disease suggests potential avenues to decrease the high incidence of graft failure in this population.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。